Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ritonavir (J05Ae03) As Part Of A So-Called Open-House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 101402083

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient ritonavir (J05AE03)within the period from March 1, 2025 to February 28, 2 027 with the possibility of concluding the contract at any time (open-house model). In the open house procedure, medicinal products in accordance with the BfArM list pursuant to Section 35 Paragraph 5a SGB V (medicines for children) are excluded.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Ritonavir (J05AE03)im Rahmen eines sogenannten Open-House-Modells.Con

Gt Ref Id - 101402083

Deadline - Dec 31, 2026